E-LIB Suche - Ergebnisse für: Goss, Glenwood

1

Biomarker-directed targeted therapy plus durvalumab in adva..:

Besse, Benjamin ; Pons-Tostivint, Elvire ; Park, Keunchil...
Nature Medicine. 30 (2024) 3 - p. 716-729 , 2024

Link: https://doi.org/10.1038/..

2

Histologic and Genotypic Characterization of Lung Cancer in..:

Goss, Glenwood D. ; Spaans, Johanna N. ; Huntsman, David...
Current Oncology. 29 (2022) 5 - p. 3171-3186 , 2022

Link: https://doi.org/10.3390/..

3

CCTG BR34: A Randomized Phase 2 Trial of Durvalumab and Tre..:

Leighl, Natasha B. ; Laurie, Scott A. ; Goss, Glenwood D....
Journal of Thoracic Oncology. 17 (2022) 3 - p. 434-445 , 2022

Link: https://doi.org/10.1016/..

4

Histologic and Genotypic Characterization of Lung Cancer in..:

Glenwood D. Goss ; Johanna N. Spaans ; David Huntsman...
https://www.mdpi.com/1718-7729/29/5/258. , 2022

Link: https://doi.org/10.3390/..

5

Histologic and Genotypic Characterization of Lung Cancer in..:

Glenwood D. Goss ; Johanna N. Spaans ; David Huntsman...
Thoracic Oncology. , 2022

Link: https://doi.org/10.3390/..

6

Tumor genomic, transcriptomic, and immune profiling charact..:

Weberpals, Johanne I. ; Pugh, Trevor J. ; Marco‐Casanova, Paola...
Cancer Medicine. 10 (2021) 9 - p. 3045-3058 , 2021

Link: https://doi.org/10.1002/..

7

Novel Nanoparticle-Based Cancer Treatment, Effectively Inhi..:

Kraus, Sarah ; Khandadash, Raz ; Hof, Raphael...
Frontiers in Oncology. 11 (2021) - p. , 2021

Link: https://doi.org/10.3389/..

8

Afatinib versus erlotinib as second-line treatment of patie..:

Goss, Glenwood D. ; Cobo, Manuel ; Lu, Shun...
eClinicalMedicine. 37 (2021) - p. 100940 , 2021

Link: https://doi.org/10.1016/..

9

Fe3O4 Nanoparticles and Paraffin Wax as Phase Change Materi..:

Cohen-Erner, Moshe ; Khandadash, Raz ; Hof, Raphael...
ACS Applied Nano Materials. 4 (2021) 10 - p. 11187-11198 , 2021

Link: https://doi.org/10.1021/..

10

Afatinib versus erlotinib as second-line treatment of patie..:

Goss, Glenwood D ; Cobo, Manuel ; Lu, Shun...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8225678/. , 2021

Link: http://www.ncbi.nlm.nih...

11

Afatinib versus erlotinib as second-line treatment of patie..:

Goss, Glenwood D ; Cobo, Manuel ; Lu, Shun...
http://hdl.handle.net/10668/18065. , 2021

Link: http://hdl.handle.net/10..

12

Afatinib versus erlotinib as second-line treatment of patie..:

Glenwood D. Goss ; Manuel Cobo ; Shun Lu...
http://www.sciencedirect.com/science/article/pii/S2589537021002200. , 2021

Link: https://doi.org/10.1016/..

13

Afatinib versus erlotinib as second-line treatment of patie..:

Goss, Glenwood D ; Cobo, Manuel ; Lu, Shun...
http://hdl.handle.net/10668/18065. , 2021

Link: http://hdl.handle.net/10..

14

Afatinib versus erlotinib as second-line treatment of patie..:

Goss, Glenwood D ; Cobo, Manuel ; Lu, Shun...
Eclinicalmedicine. , 2021

Link: https://hdl.handle.net/1..

15

Afatinib versus erlotinib as second-line treatment of patie..:

Cobo, Manuel ; Goss, Glenwood D ; Lu, Shun...
Eclinicalmedicine. , 2021

Link: https://hdl.handle.net/1..